Pharmafile Logo
Pharmafocus logo
Advanced Search

FDA accepts Dupixent for Priority Review in patients 12+ with eosinophilic esophagitis

April 4, 2022
Sales and Marketing

The FDA has accepted for Priority Review the supplemental Biologics License Application (sBLA) for Dupixent (dupilumab), in patients aged 12 …

News

New centre targets ‘undruggable’ cancers

April 4, 2022
Sales and Marketing

The new Centre for Protein Degradation has been launched, made possible by a £9 million donation to The Institute of …

News

COVID-19 vaccines now available for five to 11-year olds in England

April 4, 2022
Sales and Marketing

Parents and carers of five to 11-year olds in England can now book a low-dose COVID-19 vaccine for their children. …

News

FDA places two clinical holds on CytoDyn HIV and COVID-19 programmes

April 1, 2022
Medical Communications

The FDA has placed a partial hold on CytoDyn’s HIV program, and a full clinical hold on its COVID-19 program …

News

Biomodex launches clear cartridges for neurovascular training

April 1, 2022
Medical Communications

Biomodex has announced the launch of clear cartridges for use with Biomodex’s EVIAS and EVIAS Plus stations.The cartridges are 3D …

News

Isturisa effective in treating rare Cushing’s disease

April 1, 2022
Medical Communications

Recordati Rare Diseases has announced the publication of positive results from the Phase III LNC 4 study, confirming the efficacy …

News

UK app launched for people living with glaucoma

April 1, 2022
Medical Communications

Santen UK has launched a new app for people living with glaucoma, in partnership with Glaucoma UK, the leading charity …

News

New research finds patient satisfaction with GP services has dropped since pre-pandemic

March 31, 2022

GP leaders have said that it is ‘unsurprising’ that more people are dissatisfied with the NHS than are satisfied, and …

News

FDA approval of Cabenuva for adolescents living with HIV

March 31, 2022
Business Services

ViiV Healthcare, the global specialist HIV company, today announced the FDA approval of Cabenuva (cabotegravir, rilpivirine), for the treatment of …

News

Carteyva receives IND approval for clinical trial in second-line large b-cell lymphoma

March 31, 2022
Business Services

An investigational new drug (IND) clearance from the National Medical Products Administration (NMPA) of China, for a pivotal clinical trial …

News

250,000 with diabetes to benefit from real time information after updated NICE recommendations

March 31, 2022
Business Services

Over 250,000 people living with type 1 diabetes are set to be offered new technology to help them manage their …

News

Kesimpta-treated adults with multiple sclerosis not at risk of severe COVID-19

March 30, 2022
Business Services

The peer-reviewed journal Neurology and Therapy has published new data on COVID-19 infections in people living with remitting multiple sclerosis …

News

Carthera’s SonoCloud demonstrates potential in Alzheimer’s patients

March 30, 2022
Business Services

Carthera has announced the publication of results in the Alzheimer’s Research & Therapy Journal, from an investigator-sponsored trial evaluating the …

News

Iktos announces a collaboration with Ono for new drug design

March 30, 2022
Research and Development

Iktos, a company specialised in AI for new drug design today announced a collaboration agreement with Ono Pharmaceuticals, on innovative …

News

$24 million in grants to help end HIV epidemic across the globe

March 30, 2022
Research and Development

Gilead Sciences announced $24 million in grants to help reduce health disparities, improve access to quality healthcare, advance medical education, …

News

Margaret Keegan joins RQM+ as new CEO

March 29, 2022

RQM+, a world leading provider of regulatory, clinical and quality solutions to the MedTech industry, announced the appointment of life …

Appointment

Injecting real-world data into every day clinical trials – RWE and RWD

March 29, 2022

The past two years have seen unprecedented pressure on healthcare systems, its workers, and clinical research as a whole. COVID-19 …

Feature

Preparation Preconditions: What measures are needed to combat another pandemic?

March 29, 2022

Could we have foreseen the damage caused by the COVID-19 pandemic? This is a central question that has plagued biopharma …

Feature

CHMP recommends approval of Janssen’s first CAR-T therapy

March 29, 2022
Manufacturing and Production

Johnson & Johnson have announced the CHMP recommendation of marketing authorisation of ciltacabtagene autoleucel (cilta-cel) for the treatment of adults …

News

Telix granted FDA orphan drug designation for bone marrow conditioning treatment

March 29, 2022
Manufacturing and Production

The FDA has granted Orphan Drug Designation (ODD) for TLX66, for conditioning treatment prior to hematopoietic stem cell transplant (HSCT). …

News
The Gateway to Local Adoption Series

Latest content

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026